Standard supportive care

OTHER11 trials

Sponsors

Radiation Therapy Oncology Group, Karolinska Institutet, Case Comprehensive Cancer Center, Dana-Farber Cancer Institute, UMC Utrecht

Conditions

AcupunctureAcute Liver FailureAcute Myeloid LeukemiaBreast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)COVID-19CancerDelayed Platelet Engraftment

Phase 1

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

RecruitingNCT07321626

First Affiliated Hospital of Zhejiang UniversityAcute Myeloid Leukemia, Delayed Platelet Engraftment, HSCT +1

Start: 2025-06-01End: 2027-12-01Target: 130Updated: 2026-01-28

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

RecruitingNCT07480954

Beijing BiotechEpithelial Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma +1

Start: 2026-02-04End: 2028-05-17Target: 36Updated: 2026-03-18

Phase 2

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

CompletedNCT01262560

Radiation Therapy Oncology GroupDysphagia, Esophagitis, Lung Cancer +1

Start: 2012-02-29End: 2014-11-30Updated: 2017-08-31

Phase 3

A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

RecruitingNCT06781996

Gustave Roussy, Cancer Campus, Grand ParisBreast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start: 2025-09-09End: 2026-12-15Target: 180Updated: 2025-12-01

Phase 4

Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

TerminatedNCT04362332

UMC UtrechtCOVID-19

Start: 2020-04-14End: 2020-06-08Updated: 2020-06-19

Unknown Phase

OptiTrain - Optimal Training Women With Breast Cancer

CompletedNCT02522260

Karolinska InstitutetWell Being

Start: 2013-03-31End: 2021-06-30Updated: 2024-11-18

A Pilot Study of Structured Palliative Care for Patients Enrolled on Phase I Clinical Trials

CompletedNCT02543541

Case Comprehensive Cancer CenterCancer

Start: 2015-10-25End: 2019-01-10Updated: 2019-04-23

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

CompletedNCT02919670

Dana-Farber Cancer InstituteMultiple Myeloma, Non-Hodgkin's Lymphoma

Start: 2016-10-31End: 2020-07-31Updated: 2023-03-16

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy

Active, not recruitingNCT06190600

The Greater Poland Cancer CentreBreast Cancer

Start: 2018-10-11End: 2026-12-31Updated: 2025-04-30

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

Active, not recruitingNCT06872372

Lahore General HospitalAcute Liver Failure, Drug-Induced Liver Injury

Start: 2025-01-15End: 2025-07-15Updated: 2025-03-12

Stress Reduction Through Acupuncture

Not yet recruitingNCT07132034

University Hospital, Basel, SwitzerlandAcupuncture, Breast Cancer, Survivorship

Start: 2026-02-28End: 2028-09-30Target: 112Updated: 2026-01-14

Related Papers

A randomized trial on the feasibility of high-intensity interval training during chemotherapy in young breast cancer patients.

2025-10-28

Supervised high-intensity interval training reduces the negative effect of chemotherapy on cardiorespiratory fitness in young breast cancer women: a randomised controlled study.

2025-06-05

High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT

Cardio-Oncology2021-02-1532 citations

Amino acid mixture (enterade) as a new approach to reducing cancer therapy-induced gastrointestinal toxicity: A retrospective study.

Journal of Clinical Oncology2020-05-202 citations

A randomized, controlled trial of structured palliative care versus standard supportive care for patients enrolled on phase I clinical trials.

Journal of Clinical Oncology2020-05-201 citations

A phase II, double-blinded, randomized study using a proprietary amino acid mixture as diarrhea prevention in patients undergoing autologous stem cell transplantation (AST) for multiple myeloma (MM) and non-Hodgkin lymphoma (NHL).

Journal of Clinical Oncology2019-05-20

Two-year follow-up of the OptiTrain randomised controlled exercise trial

Breast Cancer Research and Treatment2019-03-2677 citations

The antidiarrheal efficacy of a proprietary amino acid mixture in neuroendocrine tumor (NET) patients.

Journal of Clinical Oncology2018-11-282 citations

The antidiarrheal efficacy of a proprietary amino acid mixture (enterade) in neuroendocrine tumor (NET) patients.

Journal of Clinical Oncology2018-05-202 citations

Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study

JMIR Human Factors2018-05-0831 citations

Anti-Diarrheal Efficacy of Oral Rehydration Solution in GEP-NET Patients

Oncology Times2018-04-241 citations

The antidiarrheal efficacy of a proprietary amino acid mixture in gastroenteropancreatic neuroendocrine patients.

Journal of Clinical Oncology2018-02-012 citations

Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial.

2017-11-14119 citations

Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy.

2017-02-0624 citations